Sean D. Sullivan

Sean D. Sullivan (born 1960) is an American health economist, professor, Member of the National Academies of Sciences, Engineering, and Medicine, and Fellow of the American Association for the Advancement of Science (AAAS) who has contributed to pharmacoeconomics, health technology assessment, decision sciences, drug pricing, value-based insurance design, and health coverage and reimbursement decisions.

Sullivan was dean of the University of Washington School of Pharmacy from 2014 to 2022 and past president of ISPOR. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Sean D. Sullivan', query time: 0.04s Refine Results
  1. 1
    A systematic literature review of the clinical and socioeconomic burden of bronchiectasis

    A systematic literature review of the clinical and socioeconomic burden of bronchiectasis by James D. Chalmers, Marcus A. Mall, Pamela J. McShane, Kim G. Nielsen, Michal Shteinberg, Sean D. Sullivan, Sanjay H. Chotirmall

    Published 2024-09-01
    Get full text
    Article
  2. 2
    Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer

    Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer by Elizabeth Trice Loggers, Diana S. M. Buist, Laura S. Gold, Steven Zeliadt, Rachel Hunter Merrill, Ruth Etzioni, Scott D. Ramsey, Sean D. Sullivan, Larry Kessler

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC)

    Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC) by Lisa Bloudek, Phoebe Wright, Caroline McKay, Christina Louise Derleth, Jennifer Susan Lill, Enrique Lenero, Zsolt Hepp, Scott David Ramsey, Sean D. Sullivan, Beth Devine

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing

    Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing by Erik J. Landaas MPH, Ashley M. Eckel MD, PhD, Jonathan L. Wright MD, Geoffrey S. Baird MD, PhD, Ryan N. Hansen PhD, PharmD, Sean D. Sullivan PhD

    Published 2020-11-01
    Get full text
    Article
  5. 5
    Real-world evidence for coverage determination of treatments for rare diseases

    Real-world evidence for coverage determination of treatments for rare diseases by Victoria W. Dayer, Michael F. Drummond, Omar Dabbous, Mondher Toumi, Peter Neumann, Sean Tunis, Nelson Teich, Shadi Saleh, Ulf Persson, Johann-Matthias Graf von der Schulenburg, Daniel C. Malone, Tay Salimullah, Sean D. Sullivan

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Budget impact analysis: principles of good practice. Report of the ISPOR Working Group on Good Practices for Budget Impact Analysis II, 2012

    Budget impact analysis: principles of good practice. Report of the ISPOR Working Group on Good Practices for Budget Impact Analysis II, 2012 by Sean D. Sullivan, Josephine A. Mauskopf, Federico Augustovski, J. Jaime Caro, Karen M. Lee, Mark Minchin, Ewa Orlewska, Pete Penna, Jose-Manuel Rodriguez Barrios, Wen-Yi Shau, T. L. Galankin, A. A. Mosikyan, A. S. Kolbin

    Published 2018-05-01
    Get full text
    Article

Search Tools: